BRIEF published on 05/16/2026 at 00:05, 3 months 4 days ago Onco-Innovations Advances Quality Testing for PNKP Inhibitor Cancer Research Quality Standards Onco-Innovations Limited PNKP Inhibitor Validation Clinical Trials Preparation
PRESS RELEASE published on 05/16/2026 at 00:00, 3 months 4 days ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate Onco-Innovations advances CMC program by initiating analytical method validation for ONC010 API, partnering with Dalton Pharma Services for IND-enabling studies and Phase I clinical development support IND-enabling Studies Onco-Innovations Dalton Pharma Services CMC Program Analytical Method Validation
BRIEF published on 05/13/2026 at 00:05, 3 months 7 days ago Onco-Innovations collabore avec AstraZeneca sur l'IA en oncologie Intelligence Artificielle Modélisation Prédictive Partenariat Avec AstraZeneca Collaboration En Matière De Recherche Résultats En Oncologie
BRIEF published on 05/13/2026 at 00:05, 3 months 7 days ago Onco-Innovations Collaborates with AstraZeneca on AI in Oncology Artificial Intelligence Research Collaboration Predictive Modeling AstraZeneca Partnership Oncology Outcomes
PRESS RELEASE published on 05/13/2026 at 00:00, 3 months 7 days ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI Onco-Innovations Limited announces collaboration with AstraZeneca for the PROmAI program to Predict Oncology Outcomes using Multimodal Artificial Intelligence in oncology research and development AstraZeneca Multimodal AI Onco-Innovations Limited Oncology Outcomes PROmAI Program
BRIEF published on 05/09/2026 at 00:05, 3 months 11 days ago Onco-Innovations Advances PNKP Inhibitor Development with Nucro-Technics' Bioanalysis Onco-Innovations PNKP Inhibitor Nucro-Technics Bioanalysis LC-MS
BRIEF published on 05/09/2026 at 00:05, 3 months 11 days ago Onco-Innovations fait progresser le développement d'inhibiteurs de PNKP grâce à la bioanalyse de Nucro-Technics. Onco-Innovations Inhibiteur De PNKP Nucro-Techniques LC-MS Bioanalyse
PRESS RELEASE published on 05/09/2026 at 00:00, 3 months 11 days ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology Onco-Innovations Limited announces Nucro-Technics Inc.'s advanced bioanalytical work on PNKP Inhibitor Technology, moving towards clinical evaluation Onco-Innovations Limited PNKP Inhibitor Technology Nucro-Technics Inc. Bioanalytical Work Clinical Evaluation
BRIEF published on 05/06/2026 at 00:05, 3 months 14 days ago Onco-Innovations et GSK collaborent pour améliorer les données probantes en oncologie GSK Essais Cliniques Données Du Monde Réel Oncologie Onco-Innovations
BRIEF published on 05/06/2026 at 00:05, 3 months 14 days ago Onco-Innovations and GSK Collaborate to Enhance Oncology Evidence Clinical Trials Oncology GSK Real-world Data Onco-Innovations
Published on 08/20/2026 at 02:22, 2 hours 1 minute ago Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 00:40, 3 hours 43 minutes ago Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 6 hours 23 minutes ago Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 7 hours 48 minutes ago Revive Therapeutics Announces Proposed Shares for Debt Settlement
Published on 08/20/2026 at 04:10, 12 minutes ago Shanghai Electric Contributes to World-record Biomethanol Bunkering Operation
Published on 08/20/2026 at 02:44, 1 hour 38 minutes ago Quarterly Report for Q2 and Interim Consolidated Financial Statements with Notes for the period from 1 January to 30 June 2026.
Published on 08/20/2026 at 01:45, 2 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 Annual results – Delivers on guidance and progresses key strategic actions
Published on 08/18/2026 at 18:00, 1 day 10 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 10 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 17 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 17 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 8 hours ago Aéroports de Paris S.A - July 2026 traffic figures
